Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72834 record(s)

Req # A-2016-000929

Copy of the current Risk Management Plan for Humira.

Organization: Health Canada

1094 page(s)
September 2020

Req # A-2020-000794

Requesting the rates of male babies and female babies born as a result of fertility treatments, by fertility treatment, for each fertility clinic in Ontario over the last 10 years.

Organization: Health Canada

0 page(s)
September 2020

Req # A-2017-001207

Records between Rosa Foods Inc. and Health Canada in relation to the product's classification, marketing and the decision to ban the sale of Soylent products within Canada. Records within Health Canada relating to Rosa Labs, Inc. and the recent…

Organization: Health Canada

69 page(s)
September 2020

Req # A-2019-000403

Letters from Health Canada to all applicant companies regarding any abbreviated new drug submissions (ANDSs) made since October 1, 2019 for Azacitadine.

Organization: Health Canada

1 page(s)
September 2020

Req # A-2019-000762

All material pertaining to authorizing/approving, the re-organization of the Policy and Regulatory Strategies Directorate of the Regulatory Operations and Enforcement Branch that took place beginning in approximately March 2019 up to 19 August 2019.

Organization: Health Canada

279 page(s)
September 2020

Req # A-2019-000772

Copies of all Health Canada approved product labelling for Combogesic (Drug Identification Number 02488280), including labelling materials filed and approved in both text and mock-up format. All correspondence between AFT Pharmaceuticals Limited and…

Organization: Health Canada

76 page(s)
September 2020

Req # A-2019-001221

The complete list of authorised research licence under the Cannabis Act as of 09 Oct 2019. Including any research licence authorised as a subclass at a single site.

Organization: Health Canada

5 page(s)
September 2020

Req # A-2020-000439

Adverse Reaction Report (AER) for botulinum toxin type A. Report number: E2B_03075806.

Organization: Health Canada

16 page(s)
September 2020

Req # A-2019-001393

All records prepared for the Minister or the Deputy Minister of Health Canada, related to the discovery and treatment of bedbugs, in federal buildings in the Ottawa-Gatineau area from March 31 2019 to October 31 2019.

Organization: Health Canada

52 page(s)
September 2020

Req # A-2020-000059

In relation to the Non-Insured Health Benefits Program (the “NIHB”), all final letters, memoranda, memoranda to Cabinet, briefing notes, strategic plans, data/analyses, reports/evaluations, opinions or agreements (including funding agreements),

Organization: Health Canada

0 page(s)
September 2020
Date modified: